Measuring Atopic Dermatitis Severity in Randomized Controlled Clinical Trials: What Exactly Are We Measuring?
- 1 June 2003
- journal article
- review article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 120 (6), 932-941
- https://doi.org/10.1046/j.1523-1747.2003.12251.x
Abstract
No abstract availableKeywords
This publication has 104 references indexed in Scilit:
- Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe diseaseJournal of Allergy and Clinical Immunology, 2001
- Topical Sodium Cromoglycate in the Treatment of Moderate-to-Severe Atopic DermatitisAnnals of Allergy, Asthma & Immunology, 1998
- Hydrocortisone buteprate versus betamethasone valerate for once-daily treatment of atopic dermatitisJournal of Dermatological Treatment, 1997
- Efficacy and safety of hydrolyzed cow milk and amino acid–derived formulas in infants with cow milk allergyThe Journal of Pediatrics, 1995
- Multicenter trial for long-term safety and efficacy comparison of 0.05% desonide and 1% hydrocortisone ointments in the treatment of atopic dermatitis in pediatric patientsJournal of the American Academy of Dermatology, 1995
- Ranitidine treatment of hand eczema in patients with atopic dermatitis: A double-blind, placebo-controlled trialJournal of the American Academy of Dermatology, 1995
- Moderne topische Glukokortikoide und Antiinfektiva beim superinfizierten atopischen Ekzem: Bilden Prednicarbat und Dodecyldimethylammoniumchlorid eine rationale Kombination?Infection, 1994
- Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin creamJournal of the American Academy of Dermatology, 1994
- A double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of thymopentin as an adjunctive treatment in atopic dermatitisJournal of the American Academy of Dermatology, 1994